Searchable abstracts of presentations at key conferences in endocrinology

ea0050p208 | Diabetes and Cardiovascular | SFEBES2017

Do glucocorticoids cause mitochondrial substrate switching in fetal cardiomyocytes?

Ivy Jessica , Batchen Emma , Carter Roderick , Morton Nicholas , Chapman Karen

Background: During fetal development, the heart switches substrate preference from glucose to fatty acids, such that in the adult heart, 50–70% of ATP is derived from fatty acid oxidation. What triggers this switch is currently unclear. In vivo, the late gestation rise in glucocorticoid levels is essential for structural and functional maturation of the fetal heart. Glucocorticoid treatment of fetal cardiomyocytes induces express...

ea0050p208 | Diabetes and Cardiovascular | SFEBES2017

Do glucocorticoids cause mitochondrial substrate switching in fetal cardiomyocytes?

Ivy Jessica , Batchen Emma , Carter Roderick , Morton Nicholas , Chapman Karen

Background: During fetal development, the heart switches substrate preference from glucose to fatty acids, such that in the adult heart, 50–70% of ATP is derived from fatty acid oxidation. What triggers this switch is currently unclear. In vivo, the late gestation rise in glucocorticoid levels is essential for structural and functional maturation of the fetal heart. Glucocorticoid treatment of fetal cardiomyocytes induces express...

ea0044p94 | Diabetes and Cardiovascular | SFEBES2016

Does precocious dexamethasone treatment advance fetal cardiac maturation?

Batchen Emma , Richardson Rachel , Thomson Adrian , Moran Carmel , Sooy Karen , Homer Natalie , Gray Gillian , Chapman Karen

Synthetic glucocorticoids are administered to pregnant women at risk of pre-term delivery to mature organs and improve neonatal survival. We have shown that glucocorticoid action is essential to mature the fetal heart. Here, we tested the hypotheses that antenatal glucocorticoid exposure, prior to the normal increase in glucocorticoid levels, will advance fetal heart maturation and this will depend on cardiovascular glucocorticoid receptor (GR).Male SMGR...

ea0038fp3 | (1) | SFEBES2015

Maternal genotype is an important determinant of the outcome of antenatal glucocorticoid treatment in GR+/+ and GR+/− foetal mice

Batchen Emma , Richardson Rachel , Thomson Adrian , Moran Carmel , Gray Gillian , Chapman Karen

Glucocorticoids are routinely administered to pregnant women at risk of pre-term delivery to mature foetal organs and improve neonatal survival. Previous work in glucocorticoid receptor (GR)-deficient mice showed that GR activation is essential for maturation of the foetal heart. Here, we tested the hypotheses that i) antenatal glucocorticoid exposure, prior to the normal increase in glucocorticoid levels, will advance foetal heart maturation and ii) this would depend on mater...

ea0038oc4.6 | Diabetes and cardiometabolic complications | SFEBES2015

Cardiac fibrosis and the balance between glucocorticoid and mineralocorticoid receptors signalling

Richardson Rachel , Batchen Emma , Darroch Rowan , Scullion Kathleen , Rog-Zielinska Ewa , Kenyon Christopher , Gray Gillian , Chapman Karen

Specific variations in the human glucocorticoid receptor (GR) gene associate with increased cardiovascular disease risk. GR signalling is essential for cardiac maturation in utero and adult mice with cardiomyocyte and vascular smooth muscle deletion of GR (SMGRKO mice) have cardiac hypertrophy, fibrosis and impaired function. Intriguingly, levels of left ventricle (LV) mRNA encoding the mineralocorticoid receptor (MR), which is pro-fibrotic in heart, rise postnatally ...